Press Releases
Foundation Medicine is a world-leading molecular insights company, connecting physicians and their patients to the latest cancer treatment approaches and making precision medicine a reality for thousands.
Foundation Medicine, Inc. today announced it has received approval from the U.S. Food and Drug Administration (FDA) for FoundationOne ® CDx to be used as a companion diagnostic for Piqray ® (alpelisib) in combination with fulvestrant for the treatment of postmenopausal women, and men, with hormone receptor …
CAMBRIDGE, Mass. and SAN CARLOS, Calif., September 24, 2019 – Foundation Medicine, Inc. and Natera, Inc. (NASDAQ: NTRA) today announced a partnership to develop and commercialize personalized circulating tumor DNA (ctDNA) monitoring assays, for use by biopharmaceutical and clinical customers who order FoundationOne ® …
Renowned oncology leader to head scientific innovation at Foundation Medicine CAMBRIDGE, Mass. – August 5, 2019 – Foundation Medicine, Inc. today announced the appointment of Priti Hegde, Ph.D., as chief scientific officer, effective August 5, 2019. Dr. Hegde will oversee clinical product development, cancer genomics, …
CAMBRIDGE, Mass. – July 1, 2019 – Foundation Medicine, Inc. today announced it has received approval from the U.S. Food and Drug Administration (FDA) for FoundationOne®CDx to be used as a companion diagnostic for LYNPARZA® (Olaparib) for first line maintenance therapy in BRCA-mutated advanced ovarian cancer. …
Collaboration will start with development of a companion diagnostic for Vitrakvi ® (larotrectinib), the first and only TRK inhibitor approved in the U.S. for patients with TRK fusion cancer across all solid tumors; Vitrakvi is under review in other markets around the world Goal is to advance broad patient access to …
CAMBRIDGE, Mass. – May 16, 2019 – Foundation Medicine, Inc. today announced that new data informed by the use of its portfolio of comprehensive genomic profiling (CGP) tests will be presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place from May 31 to June 4 in Chicago. The …
Journal of the American Medical Association Manuscript Supports the Value of Real-World Evidence as a Novel Method to Advance Research and Discovery Foundation Medicine and Flatiron Health today announced the publication of study results in the Journal of the American Medical Association validating that real-world …
Veterans with Advanced Cancer to Have Better Access to Foundation Medicine’s Comprehensive Genomic Profiling Tests to Help Inform Personalized Treatment Plans CAMBRIDGE, Mass. - February 5, 2019 - Foundation Medicine, Inc. today announced a nationwide contract with the U.S. Department of Veterans Affairs National …
Proven biopharma executive leader, Cindy Perettie, named as chief executive officer to succeed Troy Cox CAMBRIDGE, Mass. – January 7, 2019 – Foundation Medicine, Inc. today announced the appointment of Cindy Perettie as chief executive officer, effective February 4, 2019. Ms. Perettie will succeed Troy Cox. Ms. …
Breakthrough Approval Enables Patient Access to Comprehensive Genomic Profiling and Advances Oncology Therapy Development in Japan CAMBRIDGE, Mass.- December 27, 2018 - Foundation Medicine, Inc. today announced that Japan’s regulatory agency, the Ministry of Health, Labour and Welfare (MHLW) has approved FoundationOne …